- ￥1426 - 11914
- Candor
- 德国
- 200 050/125/500
- 2025年12月02日
快速发货
快速回复
技术支持
货源齐全
文献支持
企业认证
研选同类产品更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 用户评价
- 文献和实验
- 技术资料
- 保存条件：
2-8°C
- 保质期：
请询
- 英文名：
Candor Bioscience：LowCross® HRP
- 库存：
部分现货库存
- 供应商：
青木生物技术（武汉）有限公司
- 规格：
50 ml/125 ml/500 ml
| 规格： | 50 ml | 产品价格： | ￥1426.0 |
|---|---|---|---|
| 规格： | 125 ml | 产品价格： | ￥3174.0 |
| 规格： | 500 ml | 产品价格： | ￥11914.0 |
HRP gives peroxidase-antibody conjugates the crucial long-term stability over several years even in a ready-to-use dilution. You will be positively surprised about the enhanced long-term stability of your antibody-peroxidase-conjugates.
LowCross-Buffer® stands for superior reliability by antagonising assay interferences including HAMA-derived ones.
The efficient HAMA blocking activity of LowCross-Buffer® now also includes superior HRP-stabilization components. The result is an assay diluent for peroxidase conjugates with high reliability and convenience due to ready-to-use dilution.
文献引用：
LowCross-Buffer® stands for superior reliability by antagonising assay interferences including HAMA-derived ones.
The efficient HAMA blocking activity of LowCross-Buffer® now also includes superior HRP-stabilization components. The result is an assay diluent for peroxidase conjugates with high reliability and convenience due to ready-to-use dilution.
文献引用：
- C. Mazziotta et al. (2021). Decreased IgG Antibody Response to Viral Protein Mimotopes of Oncogenic in Cell Polyomavirus in Sera From Healthy Elderly Subjects." Frontiers in Immunology (2021): 4206. M. Park et al. (2021).
- Valproic acid protects intestinal organoids against radiation via NOTCH signaling. Cell Biology International. doi.org/10.1002/cbin.11591 D. Johnson et al. (2021).
- Sensitive assay design for detection of anti-drug antibodies to biotherapeutics that lack an immunoglobulin Fc domain. Scientific Reports, 11(1), 1-12. V. D. Gonzalez et al. (2021).
- High-grade serous ovarian tumor cells modulate NK cell function to create an immune-tolerant microenvironment. Cell Reports, 36(9), 109632. D. Junker et al. (2021).
- Reduced serum neutralization capacity against SARS-CoV-2 variants in a multiplex ACE2 RBD competition assay. medRxiv. doi.org/10.1101/2021.08.20.21262328 M. Lehmann et al. (2021).
- Human small intestinal infection by SARS-CoV-2 is characterized by a mucosal infiltration with activated CD8+ T cells. Mucosal Immunology, 1-12. R. Kant et al. (2021).
- Serendipitous COVID-19 Vaccine-Mix in Uttar Pradesh, India: Safety and Immunogenicity Assessment of a Heterologous Regime. medRxiv. doi.org/10.1101/2021.08.06.21261716 C. F. Fotis et al. (2021).
- Robust SARS-COV-2 serological population screens via multi-antigen rules-based approach. Scientific reports, 11(1), 1-11. S. Mohandas et al. (2021). Comparison of the pathogenicity and virus shedding of SARS CoV-2 VOC 202012/01 and D614G variant in hamster model. BioRxiv. doi.org/10.1101/2021.02.25.432136
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
用户评价
暂无用户评价
文献和实验该产品被引用文献
- C. Mazziotta et al. (2021). Decreased IgG Antibody Response to Viral Protein Mimotopes of Oncogenic in Cell Polyomavirus in Sera From Healthy Elderly Subjects." Frontiers in Immunology (2021): 4206. M. Park et al. (2021).
- Valproic acid protects intestinal organoids against radiation via NOTCH signaling. Cell Biology International. doi.org/10.1002/cbin.11591 D. Johnson et al. (2021).
- Sensitive assay design for detection of anti-drug antibodies to biotherapeutics that lack an immunoglobulin Fc domain. Scientific Reports, 11(1), 1-12. V. D. Gonzalez et al. (2021).
- High-grade serous ovarian tumor cells modulate NK cell function to create an immune-tolerant microenvironment. Cell Reports, 36(9), 109632. D. Junker et al. (2021).
- Reduced serum neutralization capacity against SARS-CoV-2 variants in a multiplex ACE2 RBD competition assay. medRxiv. doi.org/10.1101/2021.08.20.21262328 M. Lehmann et al. (2021).
- Human small intestinal infection by SARS-CoV-2 is characterized by a mucosal infiltration with activated CD8+ T cells. Mucosal Immunology, 1-12. R. Kant et al. (2021).
- Serendipitous COVID-19 Vaccine-Mix in Uttar Pradesh, India: Safety and Immunogenicity Assessment of a Heterologous Regime. medRxiv. doi.org/10.1101/2021.08.06.21261716 C. F. Fotis et al. (2021).
- Robust SARS-COV-2 serological population screens via multi-antigen rules-based approach. Scientific reports, 11(1), 1-11. S. Mohandas et al. (2021). Comparison of the pathogenicity and virus shedding of SARS CoV-2 VOC 202012/01 and D614G variant in hamster model. BioRxiv. doi.org/10.1101/2021.02.25.432136
研选
现货Candor Bioscience：LowCross® HRP（低交叉反应-HRP结合物稳定剂）
￥1426 - 11914
